VCEL
VCEL
NASDAQ · Biotechnology

Vericel Corp

$40.10
+0.97 (+2.48%)
As of Jun 21, 10:05 PM ET ·
Financial Highlights (FY 2026)
Revenue
283.46M
Net Income
16.95M
Gross Margin
74.4%
Profit Margin
6.0%
Rev Growth
+18.9%
D/E Ratio
0.01
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 74.4% 74.4% 63.7% 63.7%
Operating Margin 4.0% 3.6% 26.5% 24.7%
Profit Margin 6.0% 5.7% 22.8% 17.4%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 283.46M 238.42M 156.14M 179.63M
Gross Profit 210.95M 177.43M 99.49M 114.46M
Operating Income 11.34M 8.58M 41.33M 44.36M
Net Income 16.95M 12.83M 35.53M 31.27M
Gross Margin 74.4% 74.4% 63.7% 63.7%
Operating Margin 4.0% 3.6% 26.5% 24.7%
Profit Margin 6.0% 5.7% 22.8% 17.4%
Rev Growth +18.9% +18.9% +24.7% +19.3%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 5.80M 5.80M 622.73M 660.37M
Total Equity 1.02B 1.02B 997.81M 1.08B
D/E Ratio 0.01 0.01 0.62 0.61
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 23.18M 18.52M 44.60M 53.31M
Free Cash Flow 32.60M 24.70M